Curated News
By: NewsRamp Editorial Staff
September 17, 2026

SS Innovations Eyes India's Booming Medical Device Market

TLDR

  • SS Innovations targets India's $50.1B medtech market by 2030, leveraging 65.6% revenue growth and 224 robotic installations for competitive advantage.
  • SS Innovations' SSi Mantra robotic system, with 224 installations and 12,000 surgeries, drives revenue growth via telesurgery and regulatory approvals.
  • SS Innovations advances affordable robotic surgery, aiming to make quality care accessible globally and improve patient outcomes in underserved regions.
  • SS Innovations' surgical robots have performed over 12,000 surgeries across 12 countries, showcasing rapid adoption of advanced medical technology.

Impact - Why it Matters

This news matters because it highlights a significant opportunity for investors and the healthcare industry. India's medical device market is poised for explosive growth, and SS Innovations is well-positioned to capture a substantial share with its cost-effective surgical robotic systems. The company's strong financial performance and expanding global footprint demonstrate its potential to disrupt the surgical robotics market, making robotic surgery more accessible and affordable worldwide. As SSII pursues FDA clearance and CE marking, it could become a major player in the global healthcare technology sector, impacting patients, surgeons, and investors alike.

Summary

SS Innovations International (NASDAQ: SSII) is positioning itself to capitalize on India's push to grow domestic manufacturing and reduce reliance on imported medical technology. The market is projected to increase from $15.2 billion in 2025 to $50.1 billion by 2030, while government initiatives aim to strengthen the medical-device manufacturing ecosystem and increase its global market share. SSII has an established base with its proprietary SSi Mantra surgical robotic system, reporting 224 installations across 12 countries by June 30, 2026, with those systems used in more than 12,000 surgeries.

The company also reported strong first-half 2026 financials, including 65.6% year-over-year revenue growth to $25.0 million and a 77.5% increase in gross profit. Alongside expanding installations, SSII has been developing long-distance telesurgery capabilities and is pursuing U.S. FDA clearance and European CE marking for broader international commercialization. To view the full article, visit https://ibn.fm/Lb9Mw. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.

About SS Innovations International Inc.: SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary 'SSi Mantra' surgical robotic system and its comprehensive suite of 'SSi Mudra' surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. About MissionIR: MissionIR ('MIR') is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, MIR brings its clients unparalleled recognition and brand awareness. MIR is where breaking news, insightful content and actionable information converge. For more information, please visit www.MissionIR.com. Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer. MissionIR is powered by IBN.

Source Statement

This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Eyes India's Booming Medical Device Market

Blockchain registration record for this content